Innovative berry-based skin spray targets hospital-acquired bacteria

FHS
August 28, 2024
11:34 am

VTT has developed a skin spray, based on nanocellulose and antimicrobial compounds from wild berries, which can be used to treat wounds and eliminate hospital-acquired bacteria such as MRSA before surgery.

Kidney disease therapy Jardiance gains FDA approval

Jardiance is intended to treat chronic kidney disease. Credit: Pixel-Shot / Shutterstock.com. Boehringer Ingelheim and Eli Lilly and Company have received approval from the US

September 25, 2023

New dust testing methodology better protects workers from lung diseases

A new dust testing methodology developed by University of Queensland researchers offers workers better protection from diseases such as black lung and silicosis.

January 16, 2024

One-third of former professional American football players report a punch-drunk reality – CTE

Study found that one-third of former American football players reported perceived CTE, which was significantly associated with a higher risk of suicidality and mental health

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.